Kojic Acid
CAS 501-30-4
Kojic Acid (CAS 501-30-4) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 30738.25358381503 nM | 171 | - |
| - | Ki | 16023.333333333334 nM | 12 | - |
| - | MIC | 22.05 ug.mL-1 | 6 | - |
| - | IC50 | 4.546 ug.mL-1 | 5 | - |
| - | AC50 | 6177.633333333334 nM | 3 | - |
| - | Potency | 20627.75 nM | 2 | - |
| - | GI50 | 100000 nM | 1 | - |
| Tyrosinase Enzyme |
IC50 | 5.13 | - | Homo sapiens |
| Polyphenol oxidase 2 Enzyme |
Ki | 4.65 | - | Agaricus bisporus |
| D-amino-acid oxidase Enzyme |
IC50 | 5.7 | - | Homo sapiens |
| D-amino-acid oxidase Unclassified |
Ki | 4.68 | - | Sus scrofa |
| Tyrosinase Enzyme |
IC50 | 4.21 | - | Mus musculus |
| Polymerase acidic protein Enzyme |
IC50 | 4.91 | - | Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) |
| Tyrosinase Unclassified |
IC50 | 4.28 | - | Bacillus megaterium |
| Polyphenol oxidase 1 Enzyme |
IC50 | 4.82 | - | Agaricus bisporus |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| KOJIC ACID | 1426451 | SU | MTHSPL |
| Kojic Acid | 1426451 | SU | MTHSPL |
| kojic acid | 1426451 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Kojic Acid used for in pharmaceutical contexts?
Kojic Acid (CAS 501-30-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Kojic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Kojic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Kojic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Kojic Acid with EU status "restricted".
What clinical phase is Kojic Acid in?
No phase 1-4 clinical development badge is rendered for Kojic Acid because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Kojic Acid?
Kojic Acid has 15 bioactivity rows in this page query. Rendered target entries include Tyrosinase, Polyphenol oxidase 2, D-amino-acid oxidase, Polymerase acidic protein, Polyphenol oxidase 1.